Stay updated on Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.

Latest updates to the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions were provided in the change data, so there is nothing to interpret.SummaryDifference0.0%

- Check13 days agoChange DetectedThere are no additions or deletions to evaluate. The page content remains unchanged.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page revision tag was updated to v3.5.4, indicating an editorial update to the page's content or metadata. This reflects a version bump rather than a substantive change to the study details.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded TP53-focused outcome analyses for Cohort 1, specifying EFS and OS differences by TP53 status. This replaces the prior broader presence/absence approach with a gene-specific analysis in the first cohort.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site update rather than any change to the underlying study information.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.